PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC MutationsX. Le, J. Wang, X. Li et al.|Journal of Thoracic Oncology|2024Cited by 14
Spectroscopic and DFT study on the complexation of Np( <scp>v</scp> ) with amidoxime-derived ligands in aqueous solutions: speciation and structural optimizationYuxiao Guo, Chao Xu, Zhijin Zhao et al.|Dalton Transactions|2025Cited by 0